Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Effects of a novel schizophrenia risk variant rs7914558 at CNNM2 on brain structure and attributional style.

Rose EJ, Hargreaves A, Morris D, Fahey C, Tropea D, Cummings E, Caltagirone C, Bossù P, Chiapponi C, Piras F, Spalletta G, Gill M, Corvin A, Donohoe G.

Br J Psychiatry. 2014 Feb;204(2):115-21. doi: 10.1192/bjp.bp.113.131359. Epub 2013 Dec 5. Erratum in: Br J Psychiatry. 2015 Feb;206(2):169.

2.

The impact of the genome-wide supported variant in the cyclin M2 gene on gray matter morphology in schizophrenia.

Ohi K, Hashimoto R, Yamamori H, Yasuda Y, Fujimoto M, Umeda-Yano S, Fukunaga M, Watanabe Y, Iwase M, Kazui H, Takeda M.

Behav Brain Funct. 2013 Oct 25;9:40. doi: 10.1186/1744-9081-9-40.

3.

Influences of schizophrenia risk variant rs7914558 at CNNM2 on brain structure.

Ohi K.

Br J Psychiatry. 2015 Apr;206(4):343-4. doi: 10.1192/bjp.206.4.343b. No abstract available.

4.

Neural effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253.

Rose EJ, Morris DW, Hargreaves A, Fahey C, Greene C, Garavan H, Gill M, Corvin A, Donohoe G.

Am J Med Genet B Neuropsychiatr Genet. 2013 Sep;162B(6):530-7. doi: 10.1002/ajmg.b.32182. Epub 2013 Jul 10.

PMID:
23839771
5.

The miR-137 schizophrenia susceptibility variant rs1625579 does not predict variability in brain volume in a sample of schizophrenic patients and healthy individuals.

Rose EJ, Morris DW, Fahey C, Cannon D, McDonald C, Scanlon C, Kelly S, Gill M, Corvin A, Donohoe G.

Am J Med Genet B Neuropsychiatr Genet. 2014 Sep;165B(6):467-71. doi: 10.1002/ajmg.b.32249. Epub 2014 Jul 5.

PMID:
25044277
6.

Impact of the genome wide supported NRGN gene on anterior cingulate morphology in schizophrenia.

Ohi K, Hashimoto R, Yasuda Y, Nemoto K, Ohnishi T, Fukumoto M, Yamamori H, Umeda-Yano S, Okada T, Iwase M, Kazui H, Takeda M.

PLoS One. 2012;7(1):e29780. doi: 10.1371/journal.pone.0029780. Epub 2012 Jan 12.

7.

The effect of the neurogranin schizophrenia risk variant rs12807809 on brain structure and function.

Rose EJ, Morris DW, Fahey C, Robertson IH, Greene C, O'Doherty J, Newell FN, Garavan H, McGrath J, Bokde A, Tropea D, Gill M, Corvin AP, Donohoe G.

Twin Res Hum Genet. 2012 Jun;15(3):296-303. doi: 10.1017/thg.2012.7.

PMID:
22856365
8.

Volumetric abnormalities associated with cognitive deficits in patients with schizophrenia.

Wolf RC, Höse A, Frasch K, Walter H, Vasic N.

Eur Psychiatry. 2008 Dec;23(8):541-8. doi: 10.1016/j.eurpsy.2008.02.002. Epub 2008 Apr 22.

PMID:
18434103
9.

Influence of NOS1 on verbal intelligence and working memory in both patients with schizophrenia and healthy control subjects.

Donohoe G, Walters J, Morris DW, Quinn EM, Judge R, Norton N, Giegling I, Hartmann AM, Möller HJ, Muglia P, Williams H, Moskvina V, Peel R, O'Donoghue T, Owen MJ, O'Donovan MC, Gill M, Rujescu D, Corvin A.

Arch Gen Psychiatry. 2009 Oct;66(10):1045-54. doi: 10.1001/archgenpsychiatry.2009.139.

PMID:
19805695
10.

The role of the major histocompatibility complex region in cognition and brain structure: a schizophrenia GWAS follow-up.

Walters JT, Rujescu D, Franke B, Giegling I, Vásquez AA, Hargreaves A, Russo G, Morris DW, Hoogman M, Da Costa A, Moskvina V, Fernández G, Gill M, Corvin A, O'Donovan MC, Donohoe G, Owen MJ.

Am J Psychiatry. 2013 Aug;170(8):877-85. doi: 10.1176/appi.ajp.2013.12020226.

PMID:
23903335
11.

Anterior cingulate pathology and social cognition in schizophrenia: a study of gray matter, white matter and sulcal morphometry.

Fujiwara H, Hirao K, Namiki C, Yamada M, Shimizu M, Fukuyama H, Hayashi T, Murai T.

Neuroimage. 2007 Jul 15;36(4):1236-45. Epub 2007 Apr 25.

PMID:
17524666
12.

Glutamate receptor δ 1 (GRID1) genetic variation and brain structure in schizophrenia.

Nenadic I, Maitra R, Scherpiet S, Gaser C, Schultz CC, Schachtzabel C, Smesny S, Reichenbach JR, Treutlein J, Mühleisen TW, Deufel T, Cichon S, Rietschel M, Nöthen MM, Sauer H, Schlösser RG.

J Psychiatr Res. 2012 Dec;46(12):1531-9. doi: 10.1016/j.jpsychires.2012.08.026. Epub 2012 Sep 25.

PMID:
23017809
13.

Reduced anterior cingulate cognitive activation is associated with prefrontal-temporal cortical thinning in schizophrenia.

Schultz CC, Koch K, Wagner G, Nenadic I, Schachtzabel C, Güllmar D, Reichenbach JR, Sauer H, Schlösser RG.

Biol Psychiatry. 2012 Jan 15;71(2):146-53. doi: 10.1016/j.biopsych.2011.08.015. Epub 2011 Oct 2.

PMID:
21967959
14.

Effects of a genome-wide supported psychosis risk variant on neural activation during a theory-of-mind task.

Walter H, Schnell K, Erk S, Arnold C, Kirsch P, Esslinger C, Mier D, Schmitgen MM, Rietschel M, Witt SH, Nöthen MM, Cichon S, Meyer-Lindenberg A.

Mol Psychiatry. 2011 Apr;16(4):462-70. doi: 10.1038/mp.2010.18. Epub 2010 Mar 16.

PMID:
20231838
15.

ZNF804A risk allele is associated with relatively intact gray matter volume in patients with schizophrenia.

Donohoe G, Rose E, Frodl T, Morris D, Spoletini I, Adriano F, Bernardini S, Caltagirone C, Bossù P, Gill M, Corvin AP, Spalletta G.

Neuroimage. 2011 Feb 1;54(3):2132-7. doi: 10.1016/j.neuroimage.2010.09.089. Epub 2010 Oct 8.

PMID:
20934520
16.

Analysis of the VAV3 as candidate gene for schizophrenia: evidences from voxel-based morphometry and mutation screening.

Aleksic B, Kushima I, Hashimoto R, Ohi K, Ikeda M, Yoshimi A, Nakamura Y, Ito Y, Okochi T, Fukuo Y, Yasuda Y, Fukumoto M, Yamamori H, Ujike H, Suzuki M, Inada T, Takeda M, Kaibuchi K, Iwata N, Ozaki N.

Schizophr Bull. 2013 May;39(3):720-8. doi: 10.1093/schbul/sbs038. Epub 2012 Mar 13.

17.

Neuroanatomical differences between familial and sporadic schizophrenia and their parents: an optimized voxel-based morphometry study.

Lui S, Deng W, Huang X, Jiang L, Ouyang L, Borgwardt SJ, Ma X, Li D, Zou L, Tang H, Chen H, Li T, McGuire P, Gong Q.

Psychiatry Res. 2009 Feb 28;171(2):71-81. doi: 10.1016/j.pscychresns.2008.02.004. Epub 2009 Jan 24.

PMID:
19168334
18.

Impulsivity-related brain volume deficits in schizophrenia-addiction comorbidity.

Schiffer B, Müller BW, Scherbaum N, Forsting M, Wiltfang J, Leygraf N, Gizewski ER.

Brain. 2010 Oct;133(10):3093-103. doi: 10.1093/brain/awq153. Epub 2010 Jul 20.

PMID:
20647266
19.

Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253.

Donohoe G, Walters J, Hargreaves A, Rose EJ, Morris DW, Fahey C, Bellini S, Cummins E, Giegling I, Hartmann AM, Möller HJ, Muglia P, Owen MJ, Gill M, O'Donovan MC, Tropea D, Rujescu D, Corvin A.

Genes Brain Behav. 2013 Mar;12(2):203-9. doi: 10.1111/gbb.12016.

20.

A genome-wide supported psychiatric risk variant in NCAN influences brain function and cognitive performance in healthy subjects.

Raum H, Dietsche B, Nagels A, Witt SH, Rietschel M, Kircher T, Krug A.

Hum Brain Mapp. 2015 Jan;36(1):378-90. doi: 10.1002/hbm.22635. Epub 2014 Sep 13.

PMID:
25220293

Supplemental Content

Support Center